Skip to main content
. 2016 Dec 18;2016:5989681. doi: 10.1155/2016/5989681

Table 1.

Cell-cycle phase distribution (%) of 48 h JP-1-treated A549 cells.

Treatment Cell-cycle distribution
Sub-G1 (%) G0/G1 (%) S (%) G2/M (%)
Control 1.9 69.1 13.9 14.2
JP-1 150 μg/mL 2.8 67.9 14.3 13.9
JP-1 300 μg/mL 15.6 56.4 14.0 12.4
JP-1 450 μg/mL 63.8 26.1 6.1 3.7